LONG TERM USE OF CAPECITABINE IN PATIENTS WITH LOCALLY RECURRENT OR METASTATIC BREAST CANCER

被引：0
|
作者：
Josephs, D. H. [1 ]
Mir, R.
Siow, T. [1 ]
Dumas, L. E. [1 ]
Michalarea, V. [1 ]
Sawyer, E.
Mansi, J. L. [1 ]
机构：
[1] Guys & St Thomass NHS Trust, Guys Hosp, Med Oncol Off, London, England
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [1] Long term use of capecitabine in patients with locally recurrent or metastatic breast cancer
    Sirohi, B.
    Sutherland, S.
    Killick, E.
    Mikropoulos, C.
    Constantinodou, A.
    Ashley, S.
    Shaunak, N.
    O'Brien, M.
    Johnston, S.
    Smith, I. E.
    ANNALS OF ONCOLOGY, 2008, 19 : 133 - 133
  • [2] Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
    Si, W.
    Zhu, Y. Y.
    Li, Y.
    Gao, P.
    Han, C.
    You, J. H.
    Linghu, R. X.
    Jiao, S. C.
    Yang, J. L.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2013, 46 (12) : 1074 - 1081
  • [3] Capecitabine in older patients ≥70 yrs with locally advanced or metastatic breast cancer
    Kotsori, A.
    Noble, J.
    Ashley, S.
    Walsh, G.
    Smith, I.
    EJC SUPPLEMENTS, 2010, 8 (03): : 196 - 197
  • [4] Capecitabine in elderly patients with metastatic breast cancer
    De Sanctis, Rita
    Quadrini, Silvia
    Longo, Flavia
    Lapadula, Vittoria
    Restuccia, Rossella
    Del Signore, Ester
    De Filippis, Lucilla
    Stumbo, Luciano
    Gori, Bruno
    Bianco, Vincenzo
    Speranza, Iolanda
    Basile, Maria Luisa
    Di Seri, Marisa
    TUMORI, 2012, 98 (03) : 303 - 307
  • [5] Clinical predictors of long-term response to capecitabine in metastatic breast cancer (MBC).
    Kelly, Deirdre
    Lupichuk, Sasha M.
    Bedard, Philippe L.
    King, Karen
    Cescon, David W.
    Veitch, Zachary William Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Endocrine therapy in locally recurrent and metastatic breast cancer
    Tange, UB
    Mouridsen, HT
    EJC SUPPLEMENTS, 2003, 1 (06): : 275 - 286
  • [7] Phase II Study of Bevacizumab in Combination with Docetaxel and Capecitabine for the First-Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer
    Musolino, A.
    Bisagni, G.
    De Matteis, A.
    Nuzzo, F.
    Ardizzoni, A.
    Crino, L.
    Gamucci, T.
    Passalacqua, R.
    Gnoni, R.
    Boni, C.
    CANCER RESEARCH, 2010, 70
  • [8] How Long to Continue Capecitabine Chemotherapy for Metastatic Breast Cancer?
    Daheley, I.
    Wolstenholme, V.
    Gallagher, C.
    Chandler, R.
    Tipples, K.
    CLINICAL ONCOLOGY, 2016, 28 (05) : E1 - E3
  • [9] The combination of capecitabine and cyclophosphamide for metastatic breast cancer patients
    Suzuki, M.
    Kimijima, I.
    Ishii, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine
    Geva, Shahar
    Lazarev, Irena
    Geffen, David Barry
    Ariad, Samuel
    JOURNAL OF CHEMOTHERAPY, 2013, 25 (03) : 176 - 180
12345